A practical approach to the genetic neuropathies

Practical Neurology

Volumn 15, Issue 3, 2015, Pages 187-198

  Rossor, Alexander M ^a   Evans, Matthew R B ^a   Reilly, Mary M ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GENETIC SCREENING; GENETICS; HUMAN; MUTATION; NERVOUS SYSTEM DISEASES;

GENETIC TESTING; HUMANS; MUTATION; NERVOUS SYSTEM DISEASES;

EID: 84929325486     PISSN: 14747758     EISSN: 14747766     Source Type: Journal    
DOI: 10.1136/practneurol-2015-001095     Document Type: Review

References (36)

1. Reilly MM, Murphy SM, Laura M. Charcot-Marie-Tooth disease. J Peripher Nerv Syst 2011;16:1–14.
2. Houlden H, Laura M, Wavrant-De Vrieze F, et al. Mutations in the HSP27 (HSPB1) gene cause dominant, recessive, and sporadic distal HMN/CMT type 2. Neurology 2008;71:1660–8.
3. Birouk N, Gouider R, Le Guern E, et al. Charcot-Marie-Tooth disease type 1A with 17p11.2 duplication. Clinical and electrophysiological phenotype study and factors influencing disease severity in 119 cases. Brain 1997;120(Pt 5):813–23.
4. Cottenie E, Menezes MP, Rossor AM, et al. Rapidly progressive asymmetrical weakness in Charcot-Marie-Tooth disease type 4J resembles chronic inflammatory demyelinating polyneuropathy. Neuromuscul Disord 2013;23:399–403.
5. Houlden H, King R, Blake J, et al. Clinical, pathological and genetic characterization of hereditary sensory and autonomic neuropathy type 1 (HSAN I). Brain 2006;129(Pt 2):411–25.
6. Michell AW, Laura M, Blake J, et al. GJB1 gene mutations in suspected inflammatory demyelinating neuropathies not responding to treatment. J Neurol Neurosurg Psychiatry 2009;80:699–700
7. Houlden H, Laura M, Ginsberg L, et al. The phenotype of Charcot-Marie-Tooth disease type 4C due to SH3TC2 mutations and possible predisposition to an inflammatory neuropathy. Neuromuscul Disord 2009;19:264–9.
8. Murphy SM, Laura M, Blake J, et al. Conduction block and tonic pupils in Charcot-Marie-Tooth disease caused by a myelin protein zero p.Ile112Thr mutation. Neuromuscul Disord 2011;21:223–6.
9. 9 Pelayo-Negro AL, Carr AS, Laura M, et al. An observational study of asymmetry in CMT1A. J Neurol Neurosurg Psychiatry 2014.
10. Liao JP, Waclawik AJ. Nerve root hypertrophy in CMT type 1A. Neurology 2004;62:783.
11. Ishigami N, Kondo M, Nakagawa M. [Case of Charcot-Marie-Tooth disease type 1A with increased cerebrospinal fluid proteins and nerve root hypertrophy]. Rinsho Shinkeigaku 2008;48:419–21.
12. Nicholson G, Lenk GM, Reddel SW, et al. Distinctive genetic and clinical features of CMT4J: a severe neuropathy caused by mutations in the PI(3,5)P phosphatase FIG4. Brain 2011;134 (Pt 7):1959–71.
13. Udd B. Molecular biology of distal muscular dystrophies– sarcomeric proteins on top. Biochim Biophys Acta 2007;1772:145–58.
14. Horowitz SH, Schmalbruch H. Autosomal dominant distal myopathy with desmin storage: a clinicopathologic and electrophysiologic study of a large kinship. Muscle Nerve 1994;17:151–60.
15. Pitceathly RD, Murphy SM, Cottenie E, et al. Genetic dysfunction of MT-ATP6 causes axonal Charcot-Marie-Tooth disease. Neurology 2012;79:1145–54.
16. Baets J, Deconinck T, De Vriendt E, et al. Genetic spectrum of hereditary neuropathies with onset in the first year of life. Brain 2011;134(Pt 9):2664–76.
17. Murphy SM, Laura M, Fawcett K, et al. Charcot-Marie-Tooth disease: frequency of genetic subtypes and guidelines for genetic testing. J Neurol Neurosurg Psychiatry 2012;83:706–10.
18. Saporta AS, Sottile SL, Miller LJ, et al. Charcot-Marie-Tooth disease subtypes and genetic testing strategies. Ann Neurol 2011;69:22–33.
19. Thomas PK, Marques W Jr, Davis MB, et al. The phenotypic manifestations of chromosome 17p11.2 duplication. Brain 1997;120(Pt 3):465–78.
20. Shy ME, Chen L, Swan ER, et al. Neuropathy progression in Charcot-Marie-Tooth disease type 1A. Neurology 2008;70: 378–83.
21. Raeymaekers P, Timmerman V, Nelis E, et al. Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a). The HMSN Collaborative Research Group. Neuromuscul Disord 1991;1:93–7.
22. Russo M, Laura M, Polke JM, et al. Variable phenotypes are associated with PMP22 missense mutations. Neuromuscul Disord 2011;21:106–14.
23. Chance PF, Alderson MK, Leppig KA, et al. DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell 1993;72:143–51.
24. Chance PF. Inherited focal, episodic neuropathies: hereditary neuropathy with liability to pressure palsies and hereditary neuralgic amyotrophy. Neuromolecular Med 2006;8:159–74.
25. Earle N, Zochodne DW. Is carpal tunnel decompression warranted for HNPP? J Peripher Nerv Syst 2013;18:331–5.
26. Ikegami T, Ikeda H, Mitsui T, et al. Novel mutation of the myelin Po gene in a pedigree with Charcot-Marie-Tooth disease type 1B. Am J Med Genet 1997;71:246–8.
27. Verhoeven K, Claeys KG, Zuchner S, et al. MFN2 mutation distribution and genotype/phenotype correlation in Charcot-Marie-Tooth type 2. Brain 2006;129(Pt 8): 2093–102.
28. Zuchner S, Mersiyanova IV, Muglia M, et al. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet 2004;36:449–51.
29. Kleopa KA, Scherer SS. Molecular genetics of X-linked Charcot-Marie-Tooth disease. Neuromolecular Med 2006;8:107–22.
30. Dubourg O, Azzedine H, Verny C, et al. Autosomal-recessive forms of demyelinating Charcot-Marie-Tooth disease. Neuromolecular Med 2006;8:75–86.
31. Rossor AM, Polke JM, Houlden H, et al. Clinical implications of genetic advances in Charcot-Marie-Tooth disease. Nat Rev Neurol 2013;9:562–71.
32. Carr AS, Polke JM, Wilson J, et al. MFN2 deletion founder mutation in the UK population. In press.
33. Wright CF, Middleton A, Burton H, et al. Policy challenges of clinical genome sequencing. BMJ 2013;347:f6845.
34. Yagerman SE, Cross MB, Green DW, et al. Pediatric orthopedic conditions in Charcot-Marie-Tooth disease: a literature review. Curr Opin Pediatr 2012;24:50–6.
35. Walker JL, Nelson KR, Heavilon JA, et al. Hip abnormalities in children with Charcot-Marie-Tooth disease. J Pediatr Orthop 1994;14:54–9.
36. Burns J, Crosbie J, Ouvrier R, et al. Effective orthotic therapy for the painful cavus foot: a randomized controlled trial. J Am Podiatr Med Assoc 2006;96:205–11.